Key Takeaways
- IREN shares jumped approximately 6% during Monday’s premarket session following a 10.39% decline on Thursday
- Reports indicate Anthropic is seeking proposals for 1.4GW of data center infrastructure in Australia, valued between $12 billion and $15 billion, with IREN among shortlisted candidates
- Wall Street analysts maintain a Buy consensus rating with a mean price target of $81.75 — significantly higher than current price levels
- Pictet Asset Management dramatically increased its position by 349.3% during Q1, purchasing an additional 99,384 shares
- Shareholders remain wary of an $800 million equity package for founders and a sponsorship agreement with the Golden State Warriors
IREN shares experienced a premarket surge of approximately 6% on Monday, reaching around $41.05, rebounding from Thursday’s sharp 10.39% decline.
The driving force behind the rally? Reports from The Australian Financial Review’s Street Talk column revealing that Anthropic has issued a confidential request for proposals seeking a minimum of 1.4 gigawatts of data center capacity in Australia. Industry sources value the infrastructure project between $12 billion and $15 billion.
IREN has secured a position on the shortlist alongside CDC Data Centres, AirTrunk, NextDC, and Stack Infrastructure.
Anthropic has set an ambitious timeline, requiring a minimum of 1 gigawatt to become operational before the end of 2027. The AI company may opt to distribute the contract among several providers instead of selecting a sole winner.
Industry insiders suggest that Infratil-backed CDC Data Centres stands to secure the most substantial portion should Anthropic decide to split the award.
This development provided IREN with a targeted catalyst during a challenging period for AI-oriented bitcoin mining operations, which face mounting pressures from escalating infrastructure expenses, intensifying competition, and expanding capital demands.
Wall Street’s Perspective
Analyst sentiment toward IREN remains predominantly positive despite recent price weakness. The consensus recommendation stands at Buy, with a mean price objective of $81.75 — representing more than 100% upside from current trading levels.
Jefferies initiated coverage on June 18 with a Buy recommendation and $79 price target. Macquarie maintained its Outperform stance with a $90 objective on June 4. B. Riley Securities elevated its target to $96 while reaffirming Buy on the same date.
Bernstein has established a $100 price target with a Buy rating, highlighting IREN’s data center expansion initiatives as the primary growth catalyst.
Canaccord Genuity increased its target from $70 to $79 on June 3, maintaining a Buy recommendation. HC Wainwright lifted its price objective to $85 in May.
IREN’s next earnings release is slated for August 27. Analyst estimates project a loss of $0.38 per share on revenues of $165.16 million.
These figures contrast with the prior-year quarter’s loss of $0.66 per share and revenue of $187.30 million.
Corporate Governance Issues Create Headwinds
The company hasn’t been without controversy. IREN’s board approved an $800 million founder equity compensation package for its co-CEOs, coupled with a sponsorship arrangement with the Golden State Warriors.
These decisions sparked backlash from retail shareholders and market analysts, prompting scrutiny regarding capital deployment strategy and potential shareholder dilution. A director’s sale of 11,958 shares further contributed to investor unease.
Nonetheless, institutional investors have shown growing interest. Pictet Asset Management expanded its holdings by 349.3% during Q1, acquiring 99,384 additional shares to bring its total position to 127,835 shares valued at approximately $4.38 million.
Multiple other institutional investors established new positions in IREN throughout Q4, including North Star Investment Management, Clearstead Trust, and Aventura Private Wealth.
From a technical analysis perspective, IREN currently trades beneath all major moving averages. The stock sits 23.2% below its 20-day simple moving average and 24.9% under its 50-day simple moving average. Critical resistance appears near $45.50, while support exists around $36.
The stock’s 52-week trading range spans from $14.72 to $76.87, with a current market capitalization of $13.87 billion.


